Lentiviruses are a type of retrovirus that can infect both dividing and non-dividing cells, making them an attractive vector for gene therapy applications. Using lentiviral vectors, therapeutic genes can be delivered into patient cells in order to stably replace, modify or supplement defective or missing genes from a patient's genome. Lentiviral vectors are also commonly used to deliver and express chimeric antigen receptor (CAR) in T cells and other immune cells.
Our lentiviral vector product offerings include a novel p24 immunoassay, in-process potency testing tools for T cell redirecting lentivirus and a broad portfolio of genomics solutions for lentivirus characterization and analysis.
Lumit™ p24 Immunoassay
In a gene therapy workflow, reproducible detection of the p24 protein on lentivirus capsids is an essential measurement in determining lentiviral titer. Using our Lumit™ technology, we have developed an easy-to-use immunoassay that provides rapid detection of the p24 protein.
The Lumit™ p24 Immunoassay offers a simple, no-wash protocol, broad dynamic range and can be completed in as little as 30 minutes, making it a compelling alternative to conventional labor-intensive immunoassays such as ELISAs.
Lumit™ p24 Immunoassay Workflow
In-Process Potency Testing of T Cell Redirecting Lenti-CAR Virus
Lentiviral vectors are a commonly used method to deliver and express chimeric antigen receptor (CAR) in T cells and other immune cells.
We have adapted our T Cell Activation Bioassay platform for mechanism-of-action-based in-process potency testing for Lenti-CAR virus. The Lentivirus Bioassay is specific, sensitive and reproducible, and requires little hands-on time in the laboratory. The assay is stability indicating and can be easily adapted to different Lenti-CAR virus in order to target different tumor antigens.
Lentivirus Bioassay is Specific
Lentivirus Bioassay is Stability Indicating
|| % Inhibition of Max
Forced degradation samples of CAR-19 lentivirus were prepared by incubating at 37°C for 2–48 hours, then analyzed using TCR/CD3 Effector Cells and Raji Target Cells. The assay demonstrates a loss of lentiviral potency with heat treatment, as measured by an increase in EC50 and a decrease in the maximum response.
Automated RNA or DNA Extraction for Lentiviral Vector Characterization
The Maxwell RSC® Instrument is magnetic particle mover that uses prefilled cartridges and pre-programmed methods to extract DNA and/or RNA from a wide variety of sample types in 25–60 minutes.
We also have high-throughput extraction chemistries and manual extraction solutions for RNA and DNA if you are working on a smaller scale.
Workflow of gDNA Extraction for Infectious Titer Determination After Cell Transduction
Workflow of RNA Extraction for Copy Number Determination of Produced Lentiviral Vector Batches
DNA was extracted from 2 million cells transduced with 3 dilutions (1:5, 1:10, 1:20) of lentiviral vectors, as well as from cells that were not transduced (no LV). The custom Promega One4All kit extracted high-quality gDNA with absorbance ratios higher than 2, and both the DNA quality and yields meet requirements for analysis. Data courtesy of Ixaka.